Australian Clinical Labs Limited

ASX:ACL Stok Raporu

Piyasa değeri: AU$748.9m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Australian Clinical Labs Yönetim

Yönetim kriter kontrolleri 3/4

Australian Clinical Labs' CEO'su Melinda McGrath, Dec2020 tarihinde atandı, in görev süresi 3.83 yıldır. in toplam yıllık tazminatı A$ 1.56M olup, şirket hissesi ve opsiyonları dahil olmak üzere 55.9% maaş ve 44.1% ikramiyelerden oluşmaktadır. şirketin hisselerinin 1.46% ine doğrudan sahiptir ve bu hisseler A$ 11.02M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 5.3 yıl ve 3.5 yıldır.

Anahtar bilgiler

Melinda McGrath

İcra Kurulu Başkanı

AU$1.6m

Toplam tazminat

CEO maaş yüzdesi55.9%
CEO görev süresi3.8yrs
CEO sahipliği1.1%
Yönetim ortalama görev süresi5.3yrs
Yönetim Kurulu ortalama görev süresi3.5yrs

Son yönetim güncellemeleri

Recent updates

Why Investors Shouldn't Be Surprised By Australian Clinical Labs Limited's (ASX:ACL) 29% Share Price Surge

Sep 03
Why Investors Shouldn't Be Surprised By Australian Clinical Labs Limited's (ASX:ACL) 29% Share Price Surge

Should You Think About Buying Australian Clinical Labs Limited (ASX:ACL) Now?

Sep 02
Should You Think About Buying Australian Clinical Labs Limited (ASX:ACL) Now?

We Think Australian Clinical Labs (ASX:ACL) Is Taking Some Risk With Its Debt

Jun 20
We Think Australian Clinical Labs (ASX:ACL) Is Taking Some Risk With Its Debt

Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?

Feb 21
Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?

Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?

Dec 08
Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?

Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today

Aug 14
Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today

Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Feb 25
Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)

Dec 22
New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)

The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More

Dec 21
The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More

The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business

Sep 01
The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business

CEO Tazminat Analizi

Melinda McGrath'un ücretlendirmesi Australian Clinical Labs'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024AU$2mAU$873k

AU$24m

Mar 31 2024n/an/a

AU$20m

Dec 31 2023n/an/a

AU$15m

Sep 30 2023n/an/a

AU$26m

Jun 30 2023AU$1mAU$873k

AU$36m

Mar 31 2023n/an/a

AU$55m

Dec 31 2022n/an/a

AU$73m

Sep 30 2022n/an/a

AU$126m

Jun 30 2022AU$2mAU$873k

AU$178m

Mar 31 2022n/an/a

AU$156m

Dec 31 2021n/an/a

AU$134m

Sep 30 2021n/an/a

AU$97m

Jun 30 2021AU$2mAU$875k

AU$60m

Mar 31 2021n/an/a

AU$79m

Dec 31 2020n/an/a

AU$98m

Sep 30 2020n/an/a

AU$70m

Jun 30 2020AU$2mAU$852k

AU$41m

Tazminat ve Piyasa: Melinda 'ın toplam tazminatı ($USD 1.08M ) Australian pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 899.18K ).

Tazminat ve Kazançlar: Melinda şirketinin tazminatı %20'den fazla artarken, şirketin kazancı geçen yıl %20'den fazla düştü.

CEO

Melinda McGrath

3.8yrs

Görev süresi

AU$1,560,335

Tazminat

Ms. Melinda McGrath is Chief Executive Officer and Executive Director at Australian Clinical Labs Limited since December 19, 2020. She served as Chief Executive Officer and Executive Director at Clinical L...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Melinda McGrath
CEO & Executive Director3.8yrsAU$1.56m1.09%
A$ 8.1m
Darren McKee
Chief Executive Officer of Victoria1.8yrsAU$37.27kVeri yok
Matthew Cordingley
Chief Financial Officerless than a yearVeri yokVeri yok
Anthony Friedli
Chief Operating Officer8.8yrsVeri yok0%
A$ 0
Sean Jackson
Chief Information Officer9.8yrsVeri yokVeri yok
Joe Geran
National Marketing Directorno dataVeri yokVeri yok
Tony Landgren
National Medical Director & Chief Pathologist15.8yrsVeri yok0%
A$ 0
Chris Brownlow
Chief Executive Officer of New South Wales & Australian Capital Territory13.8yrsVeri yokVeri yok
Shae Seymour
Chief Executive Officer of WA/SA/NT6.8yrsVeri yokVeri yok
Eleanor Padman
Company Secretary3.5yrsVeri yokVeri yok
Rob Izzard
Chief Executive Officer of ACL Commercial Pathology1.8yrsVeri yokVeri yok

5.3yrs

Ortalama Görev Süresi

Deneyimli Yönetim: ACL 'un yönetim ekibi deneyimli ve deneyimlidir ( 5.3 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Melinda McGrath
CEO & Executive Director3.8yrsAU$1.56m1.09%
A$ 8.1m
Michael Alscher
Non-Executive Chairman1.1yrsAU$152.73k0.14%
A$ 1.0m
Christine Bartlett
Independent Non-Executive Director1.2yrsAU$111.74k0.010%
A$ 74.8k
Andrew Dutton
Independent Non-Executive Director3.5yrsAU$146.32k0.041%
A$ 306.3k
Nathanial Thomson
Non Executive Director3.8yrsAU$130.00kVeri yok
Leanne Rowe
Independent Non-Executive Director3.5yrsAU$131.18k0.0025%
A$ 18.7k
Mark Haberlin
Independent Non-Executive Director3.5yrsAU$136.23k0.024%
A$ 177.6k

3.5yrs

Ortalama Görev Süresi

64yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ACL 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.5 yıldır).